Stockscreener 앱 받기
15.95
2.05%
0.32
시간 외 거래:
15.87
-0.08
-0.50%
전일 마감가:
$15.63
열려 있는:
$15.45
하루 거래량:
64,841
Relative Volume:
0.42
시가총액:
$234.12M
수익:
-
순이익/손실:
$-21.76M
주가수익비율:
-10.30
EPS:
-1.5479
순현금흐름:
$-12.78M
1주 성능:
+1.79%
1개월 성능:
+11.15%
6개월 성능:
-40.93%
1년 성능:
+45.40%
1일 변동 폭
$15.45
$15.98
1주일 범위
$14.32
$16.02
52주 변동 폭
$7.78
$34.10
그리니치 Stock (GLSI) Company Profile
명칭
Greenwich Lifesciences Inc
전화
203-434-3290
주소
3992 BLUEBONNET DR, BUILDING 14, STAFFORD
Compare GLSI vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GLSI
Greenwich Lifesciences Inc
|
15.95 | 224.72M | 0 | -21.76M | -12.78M | -1.5479 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
그리니치 Stock (GLSI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-20 | 개시 | Noble Capital Markets | Outperform |
| 2021-09-01 | 개시 | H.C. Wainwright | Buy |
그리니치 주식(GLSI)의 최신 뉴스
Why is Greenwich LifeSciences stock rallying today? - Investing.com
Why Did GLSI Stock Rise Pre-Market Today? - Stocktwits
Greenwich (GLSI) Earnings Check: EPS Misses Its Estimate under the Current Snapshot; Post-Earnings Trading: The Share Price Sheds 0.69% on the DayAnnual Financial Report - vinanet.vn
Greenwich Lifesciences Inc (NASDAQ: GLSI) Share Price, GLSI Stock News, GLSI Share Price & Updates - Kalkine
What’s Driving GLSI Stock Today? - Stocktwits
Greenwich Lifesciences Stock Price Forecast. Should You Buy GLSI? - StockInvest.us
GLSI Q1 2026 Earnings: Wider-than-Expected Loss Reflects Clinical-Stage R&D InvestmentEarnings Revision Downgrade - vinanet.vn
Greenwich Lifesciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Greenwich LifeSciences (NASDAQ:GLSI) Posts Quarterly Earnings Results - MarketBeat
Greenwich LifeSciences 2Q 2026: Revenue $0 Net loss $(3.95M), EPS $(0.27) — 10-Q Summary - TradingView
Greenwich LifeSciences | 10-Q: Q2 2026 Earnings Report - Moomoo
Greenwich LifeSciences, Inc. (GLSI) stock price, news, quote and history - Yahoo Finance Singapore
Greenwich Lifesciences Inc expected to post a loss of 33 cents a shareEarnings Preview - TradingView
Responsive Playbooks and the GLSI Inflection - Stock Traders Daily
Greenwich LifeSciences Extends Insider and Pre-IPO Share Lock-Up to January 31, 2027 - Quiver Quantitative
Greenwich LifeSciences Directors, Officers Face 100% Lock-Up to 2027 - Stock Titan
Greenwich LifeSciences (GLSI) Expected to Post Earnings on Thursday - MarketBeat
GLSI|Greenwich Lifesciences Inc|Price:13.400|Chg%:-0.100 - TradingKey
Understanding the Setup: (GLSI) and Scalable Risk - Stock Traders Daily
Form 4 Greenwich Lifesciences Inc For: 30 July By Investing.com - Investing.com Nigeria
Greenwich LifeSciences CEO Snehal Patel buys $29,555 in stock By Investing.com - Investing.com Nigeria
Greenwich LifeSciences CEO Snehal Patel buys $20,430 in shares By Investing.com - Investing.com UK
Form 4 Greenwich Lifesciences Inc For: 29 July By Investing.com - Investing.com Canada
Greenwich LifeSciences, Inc. (GLSI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Greenwich LifeSciences (NASDAQ:GLSI) CEO Snehal Patel Purchases 2,500 Shares - MarketBeat
Greenwich Lifesciences Inc (GLSI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GLSI|Greenwich Lifesciences Inc|Price:13.470|Chg%:+0.490 - TradingKey
Form 4 Greenwich Lifesciences Inc For: 27 July By Investing.com - Investing.com Nigeria
Greenwich LifeSciences CEO buys $47,018 in company stock By Investing.com - Investing.com Canada
Greenwich LifeSciences CEO buys $47,018 in company stock - Investing.com
Greenwich LifeSciences (NASDAQ: GLSI) CEO adds 3,600 shares in open-market buys - Stock Titan
Greenwich LifeSciences, Inc. Revenue Breakdown – NASDAQ:GLSI - TradingView
Greenwich Lifesciences Inc (GLSI) Cash Flow - TradingKey
TradingKey - TradingKey
Greenwich Lifesciences Inc (GLSI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Greenwich Lifesciences Inc (GLSI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Greenwich Lifesciences Inc (GLSI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Greenwich Lifesciences Inc (GLSI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Greenwich Lifesciences Inc (GLSI) Institutional Confidence - TradingKey
Greenwich LifeSciences (GLSI) Eases 1.6% as Key Support Level Comes Into FocusStop Hunt - vinanet.vn
HC Wainwright Issues Optimistic Forecast for GLSI Earnings - MarketBeat
Greenwich LifeSciences adds up to 10 UK trial sites - grafa.com
Greenwich LifeSciences gains UK approval for breast cancer trial By Investing.com - Investing.com South Africa
Greenwich LifeSciences Gets UK Clearance to Expand Breast Cancer Trial - Moomoo
Greenwich LifeSciences gains UK approval for breast cancer trial - Investing.com
Greenwich LifeSciences secures regulatory approval to expand FLAMINGO-01 trial into United Kingdom - Traders Union
Greenwich LifeSciences Announces UK Regulatory Approval to Expand Phase III FLAMINGO-01 Breast Cancer Trial - Quiver Quantitative
Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom - The Manila Times
그리니치 (GLSI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
그리니치 주식 (GLSI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Patel Snehal | CEO and CFO |
Jul 29 '26 |
Buy |
13.10 |
700 |
9,170 |
5,611,402 |
| Patel Snehal | CEO and CFO |
Jul 27 '26 |
Buy |
13.62 |
1,500 |
20,430 |
5,609,202 |
| Patel Snehal | CEO and CFO |
Jul 23 '26 |
Buy |
13.14 |
2,500 |
32,850 |
5,606,602 |
| Patel Snehal | CEO and CFO |
Jul 24 '26 |
Buy |
12.88 |
1,100 |
14,168 |
5,607,702 |
| Patel Snehal | CEO and CFO |
Jan 13 '26 |
Buy |
29.83 |
1,800 |
53,694 |
5,604,102 |
| Patel Snehal | CEO and CFO |
Jan 12 '26 |
Buy |
27.54 |
2,900 |
79,866 |
5,602,302 |
| Patel Snehal | CEO and CFO |
Dec 31 '25 |
Buy |
21.36 |
4,300 |
91,848 |
5,599,402 |
| Patel Snehal | CEO and CFO |
Dec 30 '25 |
Buy |
21.73 |
2,900 |
63,017 |
5,595,102 |
| Patel Snehal | CEO and CFO |
Dec 18 '25 |
Buy |
12.62 |
4,100 |
51,742 |
5,592,202 |
| Patel Snehal | CEO and CFO |
Nov 25 '25 |
Buy |
8.37 |
4,600 |
38,502 |
5,588,102 |
0.86%
0.31%
자본화:
|
볼륨(24시간):